VC firms
We are a venture capitalist and private equity firm in Malaysia, providing fund on innovations focusing in healthcare, life science, biotech, agritech and more.
Overview
Investment Type
Private Equity Firm; Venture Capital
Investment Stage
Private Equity
Mentions in press and media 17
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Aug 11, 2026 | Malaysian Sovereign Wealth Fund Invests in Animal-Free Dairy Startup All G | 4 Mins Read Australian precision fermentation startup All G has welcomed Xeraya Capital, owned by Malaysia’s state-owned Khazanah Nasional fund, to its list of pre-Series B investors, a month after launching its bovine lactoferrin in the US... |
| Nov 19, 2020 | Imago raises $80M to further studies of its treatment for blood and bone-marrow disorders | The drug works by inhibiting an enzyme called lysine-specific demethylase, or LSD1, which plays a role in the progression of the diseases for which bomedemstat is indicated The Food and Drug Administration has given bomedemstat breakthrough... |
| Feb 28, 2020 | StartUPDATES: New developments for healthcare startups | As the Airbnb for medical office timesharing, Healco fosters a mutually beneficial relationship – one where lessee and lessor are able to maximize effectiveness and minimize cost, all while feeling in-control. Historically, the medical offi... |
| Feb 26, 2020 | Aria CV nets $31M to support first US clinical study of its implant | “This will be the first implant for the treatment of pulmonary arterial hypertension,” said Gladney, an early investor in Aria CV who has been its CEO since April. He had previously been on the company’s board. The implant – known as the Ar... |
| May 8, 2018 | Rapid Micro Biosystems Secures $60 Million In Equity Financing | Investment to Accelerate Company’s Continued Global Commercial Expansion and Product Innovation Lowell, MA – May 2, 2018 – Rapid Micro Biosystems, the leading provider of automated, growth-based, rapid microbial detection technology for th... |
| Sep 8, 2016 | Chrono Therapeutics raises $47.6M for smoking cessation wearable to deliver nicotine fix before you wake | The wearable also has a “crave” button users can press that records the moment they want a cigarette and triggers an immediate coaching message through the app to help the user get through the moment without smoking. There is also a behavio... |
| Aug 6, 2015 | Why MLS Capital Fund II Invested in Provivi & GreenLight Biosciences | MLS Capital Fund II, co-managed by Spruce Capital Partners and Xeraya Capital, announced the first two investments from the fund at the 12th Annual BIO World Congress on Industrial Biotechnology on July 21, 2015. Provivi, a bio-based pest c... |
| Jul 24, 2015 | News in Brief: AgTech Sectors that Scored Funds this Week | Catch up on recent fundings in AgTech with the following list of News in Brief. Biotech Companies Boost their Bucks The MLS Capital Fund II has announced its first two investments — both in biotech. Co-managed by Spruce Capital Partners and... |
| Jan 8, 2015 | Spruce, Xeraya raise $150m in 2nd MLSCF | Premium Spruce Capital Partners LLC and Xeraya Capital have raised $150 million in the first close of their MLS Capital Fund II, the successor fund to the $162 million Malaysian Life Sciences Capital Fund. Continue reading this story with a... |
Show more
Reviews 0
FAQ about Xeraya Capital
What has the press written about Xeraya Capital?
Parsers VC has collected 17 articles mentioning Xeraya Capital, among them “Malaysian Sovereign Wealth Fund Invests in Animal-Free Dairy Startup All G” (Aug 11, 2026) and “Imago raises $80M to further studies of its treatment for blood and bone-marrow disorders” (Nov 19, 2020).
Is Xeraya Capital still active?
Yes, Xeraya Capital is active; its latest activity on Parsers VC dates from Aug 20, 2026.